BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12673730)

  • 1. Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults.
    Komdeur R; Klunder J; van der Graaf WT; van den Berg E; de Bont ES; Hoekstra HJ; Molenaar WM
    Cancer; 2003 Apr; 97(8):1999-2005. PubMed ID: 12673730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of multidrug resistance-associated proteins in rhabdomyosarcomas before and after chemotherapy: the relationship between lung resistance-related protein (LRP) and differentiation.
    Klunder JW; Komdeur R; Van Der Graaf WT; De Bont EJ; Hoekstra HJ; Van Den Berg E; Molenaar WM
    Hum Pathol; 2003 Feb; 34(2):150-5. PubMed ID: 12612883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug resistance-related markers in primary neuroblastoma.
    Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
    Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells.
    Pituch-Noworolska A; Zaremba M; Wieczorek A
    Pol J Pathol; 2009; 60(4):168-73. PubMed ID: 20072950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
    Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
    Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer].
    Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C
    Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of multidrug resistance-associated genes after chemotherapy in pediatric solid malignancies.
    Oue T; Yoneda A; Uehara S; Yamanaka H; Fukuzawa M
    J Pediatr Surg; 2009 Feb; 44(2):377-80. PubMed ID: 19231538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma.
    Krishnakumar S; Mallikarjuna K; Desai N; Muthialu A; Venkatesan N; Sundaram A; Khetan V; Shanmugam MP
    Br J Ophthalmol; 2004 Dec; 88(12):1521-6. PubMed ID: 15548804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
    Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.
    Citti A; Boldrini R; Inserra A; Alisi A; Pessolano R; Mastronuzzi A; Zin A; De Sio L; Rosolen A; Locatelli F; Fruci D
    Int J Oncol; 2012 Jul; 41(1):117-24. PubMed ID: 22504834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy.
    Rudas M; Filipits M; Taucher S; Stranzl T; Steger GG; Jakesz R; Pirker R; Pohl G
    Breast Cancer Res Treat; 2003 Sep; 81(2):149-57. PubMed ID: 14572157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma.
    Ohsawa M; Ikura Y; Fukushima H; Shirai N; Sugama Y; Suekane T; Hirayama M; Hino M; Ueda M
    Oncology; 2005; 68(4-6):422-31. PubMed ID: 16020972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
    Styczynski J; Wysocki M; Debski R; Czyzewski K; Kolodziej B; Rafinska B; Kubicka M; Koltan S; Koltan A; Pogorzala M; Kurylak A; Olszewska-Slonina D; Balwierz W; Juraszewska E; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Malinowska I; Stanczak E; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Maciejka-Kapuscinska L
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):875-93. PubMed ID: 17671794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
    Arts HJ; Katsaros D; de Vries EG; Massobrio M; Genta F; Danese S; Arisio R; Scheper RJ; Kool M; Scheffer GL; Willemse PH; van der Zee AG; Suurmeijer AJ
    Clin Cancer Res; 1999 Oct; 5(10):2798-805. PubMed ID: 10537344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias--correlation to the expression of multidrug resistance proteins.
    Fichtner I; Paal K; Borgmann A; Badiali L; Wurm R; Henze G
    Anticancer Res; 2003; 23(3B):2657-64. PubMed ID: 12894554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.
    Diestra JE; Condom E; Del Muro XG; Scheffer GL; Pérez J; Zurita AJ; Muñoz-Seguí J; Vigués F; Scheper RJ; Capellá G; Germà-Lluch JR; Izquierdo MA
    J Urol; 2003 Oct; 170(4 Pt 1):1383-7. PubMed ID: 14501774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance proteins in primary and metastatic soft-tissue sarcomas: down-regulation of P-glycoprotein during metastatic progression.
    Komdeur R; Molenaar WM; Zwart N; Hoekstra HJ; van den Berg E; van der Graaf WT
    Anticancer Res; 2004; 24(1):291-5. PubMed ID: 15015610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia.
    El-Sharnouby JA; Abou El-Enein AM; El Ghannam DM; El-Shanshory MR; Hagag AA; Yahia S; Elashry R
    J Oncol Pharm Pract; 2010 Sep; 16(3):179-88. PubMed ID: 19969624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.